Source-linked briefing Health

NHS Approves New Drugs for Rare Blood Cancers

NHS Approves New Drugs for Rare Blood Cancers

Wired Gov reports a landmark NHS decision enabling hundreds of patients, including infants and young children, to access new life‑saving treatments for rare blood cancers. The approvals are expected to broaden options and improve outcomes for hard‑to‑treat conditions.

Original headline

Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers